Peanut in Household Dust Linked to Peanut Allergies, Especially for Children with Eczema
Exposure to peanut proteins in household dust may be a trigger of peanut allergy, according to a study published today in the Journal of Allergy and Clinical Immunology.
The study was conducted in 359 children aged 3-15 months taking part in the NIH-sponsored Consortium for Food Allergy Research (CoFAR) study. These children were at high risk of developing a peanut allergy based on having likely milk or egg allergy or eczema. The study found that the risk of having strong positive allergy tests to peanut increased with increasingly higher amounts of peanut found in living room dust.
"The relationship was especially strong among children with more severe atopic dermatitis (eczema), suggesting that exposure to peanut in the environment through an impaired skin barrier could be a risk," said Hugh Sampson, MD, Professor of Pediatrics, Dean for Translational Biomedical Sciences at the Icahn School of Medicine, Director of the Jaffe Food Allergy Institute at The Mount Sinai Hospital, and the Principal Investigator for the CoFAR.
Scott H. Sicherer, MD, a lead investigator for the study and the Elliot and Roslyn Jaffe Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai, noted that it is too early to make recommendations based on these results and that more research is needed. "We need to see if early interventions, such as earlier food consumption, improving the damaged skin barrier, or reducing household exposure will counter the development of the allergy."
The study was performed in collaboration with 4 other sites in the United States and with researchers at King’s College in London.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.